Jasper Therapeutics, Inc. (JSPR)
0.51
+0.01
(+2.91%)
USD |
NASDAQ |
Oct 23, 16:00
0.52
+0.01
(+1.96%)
Pre-Market: 20:00
Jasper Therapeutics Market Cap : 14.32M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 14.32M |
| October 22, 2026 | 13.92M |
| October 21, 2026 | 14.16M |
| October 20, 2026 | 14.04M |
| October 19, 2026 | 13.41M |
| October 16, 2026 | 13.48M |
| October 15, 2026 | 14.94M |
| October 14, 2026 | 14.07M |
| October 13, 2026 | 13.92M |
| October 12, 2026 | 15.58M |
| October 09, 2026 | 16.01M |
| October 08, 2026 | 15.72M |
| October 07, 2026 | 16.00M |
| October 06, 2026 | 15.73M |
| October 05, 2026 | 16.65M |
| October 02, 2026 | 15.87M |
| October 01, 2026 | 16.79M |
| September 30, 2026 | 16.29M |
| September 29, 2026 | 17.56M |
| September 28, 2026 | 17.58M |
| September 25, 2026 | 17.10M |
| September 24, 2026 | 16.44M |
| September 23, 2026 | 15.92M |
| September 22, 2026 | 17.49M |
| September 21, 2026 | 16.92M |
| Date | Value |
|---|---|
| September 18, 2026 | 17.35M |
| September 17, 2026 | 17.81M |
| September 16, 2026 | 16.31M |
| September 15, 2026 | 16.01M |
| September 14, 2026 | 17.77M |
| September 11, 2026 | 18.54M |
| September 10, 2026 | 19.68M |
| September 09, 2026 | 19.68M |
| September 08, 2026 | 19.92M |
| September 04, 2026 | 19.90M |
| September 03, 2026 | 19.27M |
| September 02, 2026 | 19.79M |
| September 01, 2026 | 19.59M |
| August 31, 2026 | 19.98M |
| August 28, 2026 | 19.65M |
| August 27, 2026 | 19.63M |
| August 26, 2026 | 20.16M |
| August 25, 2026 | 20.22M |
| August 24, 2026 | 20.28M |
| August 21, 2026 | 20.10M |
| August 20, 2026 | 19.41M |
| August 19, 2026 | 20.96M |
| August 18, 2026 | 21.06M |
| August 17, 2026 | 23.65M |
| August 14, 2026 | 22.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| Price to Book Value | 10.13 |
| Price | 0.51 |
| Earnings Yield | -310.0% |